Age of the Donor Reduces the Ability of Human Adipose-Derived Stem Cells to Alleviate Symptoms in the Experimental Autoimmune Encephalomyelitis Mouse Model

There is a significant clinical need for effective therapies for primary progressive multiple sclerosis, which presents later in life (i.e., older than 50 years) and has symptoms that increase in severity without remission. With autologous mesenchymal stem cell therapy now in the early phases of cli...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Scruggs, Brittni A., Semon, Julie A., Zhang, Xiujuan, Zhang, Shijia, Bowles, Annie C., Pandey, Amitabh C., Imhof, Kathleen M.P., Kalueff, Allan V., Gimble, Jeffrey M., Bunnell, Bruce A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: AlphaMed Press 2013
Schlagworte:
Tissue Engineering and Regenerative Medicine
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3785264/
https://ncbi.nlm.nih.gov/pubmed/24018793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2013-0026
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge